Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects
- 10 June 2011
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (17), 2301-2304
- https://doi.org/10.1200/jco.2010.32.3550
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Improved Endpoints for Cancer Immunotherapy TrialsJNCI Journal of the National Cancer Institute, 2010
- Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptionsCancer Causes & Control, 2008
- Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?Nature Reviews Cancer, 2007
- Concordance among Gene-Expression–Based Predictors for Breast CancerThe New England Journal of Medicine, 2006
- Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast CancerBreast Cancer Research and Treatment, 2006
- Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast CancerJAMA, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Hazard rates of recurrence following diagnosis of primary breast cancerBreast Cancer Research and Treatment, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958